CA996112A - Propanolamine derivatives - Google Patents

Propanolamine derivatives

Info

Publication number
CA996112A
CA996112A CA148,657A CA148657A CA996112A CA 996112 A CA996112 A CA 996112A CA 148657 A CA148657 A CA 148657A CA 996112 A CA996112 A CA 996112A
Authority
CA
Canada
Prior art keywords
propanolamine derivatives
propanolamine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA148,657A
Other languages
English (en)
Other versions
CA148657S (en
Inventor
Joachim Augstein
Allan L. Ham
David A. Cox
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp
Original Assignee
Pfizer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp filed Critical Pfizer Corp
Application granted granted Critical
Publication of CA996112A publication Critical patent/CA996112A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C07D233/36—One oxygen atom with hydrocarbon radicals, substituted by nitrogen atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
CA148,657A 1971-08-04 1972-08-03 Propanolamine derivatives Expired CA996112A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3660671 1971-08-04

Publications (1)

Publication Number Publication Date
CA996112A true CA996112A (en) 1976-08-31

Family

ID=10389666

Family Applications (1)

Application Number Title Priority Date Filing Date
CA148,657A Expired CA996112A (en) 1971-08-04 1972-08-03 Propanolamine derivatives

Country Status (13)

Country Link
US (1) US3852291A (es)
JP (1) JPS587629B2 (es)
AR (3) AR196078A1 (es)
AU (1) AU461863B2 (es)
BE (1) BE787103A (es)
CA (1) CA996112A (es)
CH (1) CH555342A (es)
DE (1) DE2238504C3 (es)
ES (1) ES405544A1 (es)
FR (1) FR2150728B1 (es)
GB (1) GB1345075A (es)
IE (1) IE36611B1 (es)
SE (1) SE409862B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4195090A (en) * 1973-02-20 1980-03-25 Ciba-Geigy Corporation 2-(3-Amino-2-hydroxy-propoxy)pyridine derivatives and pharmaceutical compositions therewith
US4410530A (en) * 1973-02-20 1983-10-18 Ciba-Geigy Corporation 2-(3-Amino-2-hydroxy-propoxy)-mono-and diazines
US4020071A (en) * 1973-12-20 1977-04-26 Cassella Farbwerke Mainkur Aktiengesellschaft Derivatives of 1-phenoxy-3-amino-propan-2-ol
US4066768A (en) * 1973-12-27 1978-01-03 Cassella Farbwerke Mainkur Aktiengesellschaft Derivatives of 1-phenoxy-3-amino-propan-2-ol
US4088764A (en) * 1973-12-27 1978-05-09 Cassella Farbwerke Mainkur Aktiengesellschaft Pharmaceutically active derivatives of 1-phenoxy-3-amino-propan-2-ol
US4041076A (en) 1974-10-23 1977-08-09 Hoffmann-La Roche Inc. Immunoassay for pharmacologically active phenethylamines
DE2609645A1 (de) * 1976-03-09 1977-09-15 Boehringer Sohn Ingelheim Aminoalkylheterocyclen
DE2644833A1 (de) * 1976-10-05 1978-04-20 Boehringer Sohn Ingelheim Neue 1-aryloxy-2-hydroxy-3-alkylenaminopropane und verfahren zu ihrer herstellung
LU77339A1 (es) * 1977-05-16 1979-01-19
US4234595A (en) * 1977-07-13 1980-11-18 Mead Johnson & Company 3-Indolyl-tertiary butylaminopropanols
DE2833140A1 (de) * 1978-07-28 1980-02-07 Boehringer Sohn Ingelheim Neue n-substituierte heterocyclen
US4319032A (en) * 1980-06-06 1982-03-09 Alcolac Inc. Derivatives of aminoalkyl alkylene ureas
DE3023369A1 (de) * 1980-06-23 1982-01-14 Boehringer Mannheim Gmbh, 6800 Mannheim Aryloxypropanolamine, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
CA1269378A (en) * 1981-10-23 1990-05-22 George Emile Abboud Polymerisable monomers, polymer dispersions and derived paints
FR2523965B1 (fr) * 1982-03-24 1985-09-27 Bellon Labor Sa Roger (benzimidazolyl-1)-1, n-((hydroxy-4 methoxy-3 phenyl)-2 hydroxy-2 ethyl) amino-3 butane et ses sels a activite b-adrenergique, leurs applications therapeutiques, et procede pour les preparer
US4634713A (en) * 1982-05-28 1987-01-06 Ciba-Geigy Corporation Antihypertensive 3-(ureidocyclohexyleneamino)propane-1,2-diol derivatives
IT1193608B (it) * 1983-01-21 1988-07-21 Pierrel Spa Derivati di arilossipropanolamina,procedimento per la loro preparazione composizioni farmaceutiche che li contengono e loro impiego terapeutico
US4593039A (en) * 1984-04-02 1986-06-03 Merck & Co., Inc. 1-aryloxy-3-(substituted aminoalkylamino)-2-propanols
US5008267A (en) * 1988-10-29 1991-04-16 Mitsui Toatsu Chemicals, Incorporated Pyrimidinedione compounds, method of producing the same and antiarrythmic agents containing the same
JP2815218B2 (ja) * 1990-04-13 1998-10-27 三井化学株式会社 ピリミジンジオン誘導体、およびそれを含有する抗不整脈剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2883381A (en) * 1959-04-21 New process for the production of hy-
CH546242A (de) * 1969-01-24 1974-02-28 Ciba Geigy Ag Verfahren zur herstellung von neuen dialkoholen von zwei n-heterocyclische ringe enthaltenden verbindungen.

Also Published As

Publication number Publication date
AR196078A1 (es) 1973-11-30
AR196011A1 (es) 1973-11-23
GB1345075A (en) 1974-01-30
SE409862B (sv) 1979-09-10
AU4541772A (en) 1974-02-14
FR2150728A1 (es) 1973-04-13
AU461863B2 (en) 1975-06-05
IE36611L (en) 1973-02-04
DE2238504B2 (de) 1979-07-19
BE787103A (fr) 1973-02-02
FR2150728B1 (es) 1976-04-16
JPS4828467A (es) 1973-04-14
AR197038A1 (es) 1974-03-08
ES405544A1 (es) 1975-07-16
IE36611B1 (en) 1976-12-08
DE2238504C3 (de) 1980-03-20
DE2238504A1 (de) 1973-02-22
JPS587629B2 (ja) 1983-02-10
US3852291A (en) 1974-12-03
CH555342A (de) 1974-10-31

Similar Documents

Publication Publication Date Title
CA996112A (en) Propanolamine derivatives
AU468250B2 (en) 3-nitropyrazole derivatives
AU462723B2 (en) 2-nitro-5-imidazolyaldehyde derivatives
AU461957B2 (en) Lumilysergol derivatives
CA1017335A (en) Triazolyl-ethenyl-phenylene derivatives
AU3845772A (en) Dibenzocycloheptadioxolan derivatives
AU470552B2 (en) Aminocephalosporin derivatives
AU472069B2 (en) Dibenzoxirenazepine derivatives
CA867769A (en) Fluoracylamino-trichloromethyl-methane derivatives
CA866804A (en) Spiro-azatetramethylene derivatives
AU454731B2 (en) Pyrazinylurea derivatives
CA862754A (en) Benzothiazepin-4-one derivatives
CA863356A (en) Indenopyridine derivatives
CA863950A (en) Thienobenzothiazephine derivatives
AU463550B2 (en) Nitrofurylpyrimidine derivatives
AU479054B2 (en) Triazole-ethenyl-phenylene derivatives
AU475768B2 (en) Ergolene derivatives
AU475691B2 (en) 7-amino-indazole derivatives
CA868361A (en) Thieno-benzothiazine derivatives
CA869544A (en) Thieno-benzothiazine derivatives
CA874996A (en) Diaryloxalamide derivatives
CA871716A (en) Norscopolamine derivatives
CA871723A (en) Pyridyl-2-imidazolone derivatives
CA879692A (en) Benzazocine derivatives
CA880321A (en) Tropanol derivatives